Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV.

Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, Huang FC, Wu SF, Chen SC, Wen WH, Chu CH, Ni YH, Hsu HY, Tsai PL, Chiang CL, Shyu MK, Lee PI, Chang FY, Chang MH.

Gastroenterology. 2012 Apr;142(4):773-781.e2. doi: 10.1053/j.gastro.2011.12.035. Epub 2011 Dec 23.

PMID:
22198276
2.

Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.

Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L.

Vaccine. 2014 Oct 21;32(46):6091-7. doi: 10.1016/j.vaccine.2014.08.078. Epub 2014 Sep 18.

PMID:
25240752
3.

Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.

Eke AC, Eleje GU, Eke UA, Xia Y, Liu J.

Cochrane Database Syst Rev. 2017 Feb 11;2:CD008545. doi: 10.1002/14651858.CD008545.pub2. Review.

PMID:
28188612
4.

Hepatitis B vaccination in children: the Taiwan experience.

Ni YH, Chen DS.

Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29.

PMID:
20116181
5.

[Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].

Yin YZ, Zhou J, Zhang PZ, Hou HY.

Zhonghua Gan Zang Bing Za Zhi. 2013 Feb;21(2):105-10. doi: 10.3760/cma.j.issn.1007-3418.2013.02.008. Chinese.

PMID:
23663881
6.

Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.

Evans AA, Cohen C, Huang P, Qian L, London WT, Block JM, Chen G.

Vaccine. 2015 Jun 12;33(26):3010-5. doi: 10.1016/j.vaccine.2015.01.054. Epub 2015 Feb 16.

7.

Chronic HBV infection among pregnant women and their infants in Shenyang, China.

Ding Y, Sheng Q, Ma L, Dou X.

Virol J. 2013 Jan 7;10:17. doi: 10.1186/1743-422X-10-17.

8.

A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.

Zhang L, Gui X, Wang B, Ji H, Yisilafu R, Li F, Zhou Y, Zhang L, Zhang H, Liu X.

Eur J Pediatr. 2014 Sep;173(9):1161-8. doi: 10.1007/s00431-014-2305-7. Epub 2014 Apr 5.

PMID:
24699981
9.

Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.

Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, Jourdain G, Moreau A, Borkird T, Layangool P, Kamonpakorn N, Jitphiankha W, Kwanchaipanich R, Potchalongsin S, Lallemant M, Sirirungsi W, Goudeau A; Program for HIV Prevention and Treatment (PHPT) group.

J Clin Virol. 2013 Oct;58(2):415-21. doi: 10.1016/j.jcv.2013.06.025. Epub 2013 Aug 2.

11.

Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin.

Guo Y, Zhang W, Zhang Y, Lin X, Zhang B, Chen C, Du Y.

Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1363-9. doi: 10.1097/MEG.0b013e32835847c6.

PMID:
22922527
12.
13.

Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.

Lu LL, Chen BX, Wang J, Wang D, Ji Y, Yi HG, Chen T, Zhang Y, Petersen E, Li Q, Qu C.

Int J Infect Dis. 2014 Nov;28:41-4. doi: 10.1016/j.ijid.2014.07.028. Epub 2014 Sep 19.

14.

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.

Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX.

J Hepatol. 2011 Dec;55(6):1215-21. doi: 10.1016/j.jhep.2011.02.032. Epub 2011 Apr 15.

PMID:
21703206
15.

Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.

Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih HH, Chang MH.

Pediatr Infect Dis J. 2003 Jul;22(7):584-8.

PMID:
12867831
16.

Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection.

Tseng YR, Wu JF, Ni YH, Chen HL, Chen CC, Wen WH, Hsu HY, Chang MH.

Liver Int. 2011 Oct;31(9):1373-80. doi: 10.1111/j.1478-3231.2011.02574.x. Epub 2011 Jun 28.

PMID:
21745315
17.

Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.

Chen SC, Toy M, Yeh JM, Wang JD, Resch S.

Pediatrics. 2013 Apr;131(4):e1135-43. doi: 10.1542/peds.2012-1262. Epub 2013 Mar 25. Erratum in: Pediatrics. 2014 Feb;133(2):346.

18.

Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial.

Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, Bhutia K, Gupta E, Mukhopadhyay CK, Dutta AK, Trivedi SS.

J Viral Hepat. 2013 Nov;20(11):801-10. doi: 10.1111/jvh.12102. Epub 2013 Apr 23.

PMID:
24168259
19.

Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus.

Hu Y, Chen J, Wen J, Xu C, Zhang S, Xu B, Zhou YH.

BMC Pregnancy Childbirth. 2013 May 24;13:119. doi: 10.1186/1471-2393-13-119.

20.

#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.

Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, Silverman NS.

Am J Obstet Gynecol. 2016 Jan;214(1):6-14. doi: 10.1016/j.ajog.2015.09.100. Epub 2015 Oct 8. Review.

PMID:
26454123

Supplemental Content

Support Center